rs138301233

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_144670.6(A2ML1):​c.2027G>A​(p.Arg676Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000139 in 1,610,310 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 18/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R676W) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00066 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000084 ( 0 hom. )

Consequence

A2ML1
NM_144670.6 missense, splice_region

Scores

19
Splicing: ADA: 0.00004369
2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.12

Publications

1 publications found
Variant links:
Genes affected
A2ML1 (HGNC:23336): (alpha-2-macroglobulin like 1) This gene encodes a member of the alpha-macroglobulin superfamily. The encoded protein is thought to be an N-glycosylated monomeric protein that acts as an inhibitor of several proteases. It has been shown to form covalent interactions with proteases, and has been reported as the p170 antigen recognized by autoantibodies in the autoimmune disease paraneoplastic pemphigus (PNP; PMID:20805888). Mutations in these gene have also been associated with some cases of Noonan syndrome (NS; PMID:24939586) as well as some cases of otitis media (PMID:26121085). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
A2ML1 Gene-Disease associations (from GenCC):
  • Noonan syndrome
    Inheritance: AD Classification: SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0055425763).
BP6
Variant 12-8848913-G-A is Benign according to our data. Variant chr12-8848913-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 241888.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 101 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
A2ML1NM_144670.6 linkc.2027G>A p.Arg676Gln missense_variant, splice_region_variant Exon 16 of 36 ENST00000299698.12 NP_653271.3 B3KVV6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
A2ML1ENST00000299698.12 linkc.2027G>A p.Arg676Gln missense_variant, splice_region_variant Exon 16 of 36 1 NM_144670.6 ENSP00000299698.7 A8K2U0-1

Frequencies

GnomAD3 genomes
AF:
0.000664
AC:
101
AN:
152132
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00222
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000208
AC:
51
AN:
244686
AF XY:
0.0000979
show subpopulations
Gnomad AFR exome
AF:
0.00253
Gnomad AMR exome
AF:
0.000328
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000466
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000844
AC:
123
AN:
1458058
Hom.:
0
Cov.:
30
AF XY:
0.0000731
AC XY:
53
AN XY:
725204
show subpopulations
African (AFR)
AF:
0.00253
AC:
84
AN:
33240
American (AMR)
AF:
0.000295
AC:
13
AN:
44022
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25978
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39650
South Asian (SAS)
AF:
0.0000117
AC:
1
AN:
85478
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53368
Middle Eastern (MID)
AF:
0.000555
AC:
3
AN:
5404
European-Non Finnish (NFE)
AF:
0.00000720
AC:
8
AN:
1110724
Other (OTH)
AF:
0.000216
AC:
13
AN:
60194
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000663
AC:
101
AN:
152252
Hom.:
1
Cov.:
32
AF XY:
0.000564
AC XY:
42
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00222
AC:
92
AN:
41530
American (AMR)
AF:
0.000458
AC:
7
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68020
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000265
Hom.:
0
Bravo
AF:
0.000805
ESP6500AA
AF:
0.00288
AC:
11
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000215
AC:
26
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 12, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 09, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
12
DANN
Benign
0.44
DEOGEN2
Benign
0.0045
T;T;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.0046
N
LIST_S2
Benign
0.67
T;T;T
M_CAP
Benign
0.0018
T
MetaRNN
Benign
0.0055
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-0.97
N;.;.
PhyloP100
1.1
PrimateAI
Benign
0.20
T
PROVEAN
Benign
-0.12
N;N;N
REVEL
Benign
0.021
Sift
Benign
0.95
T;T;T
Sift4G
Benign
0.85
T;T;T
Polyphen
0.0
B;.;.
Vest4
0.064
MVP
0.072
MPC
0.12
ClinPred
0.0092
T
GERP RS
0.59
Varity_R
0.030
gMVP
0.17
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000044
dbscSNV1_RF
Benign
0.0060
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138301233; hg19: chr12-9001509; API